These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24930933)

  • 21. Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function.
    Meyer C; Heiss C; Drexhage C; Kehmeier ES; Balzer J; Mühlfeld A; Merx MW; Lauer T; Kühl H; Floege J; Kelm M; Rassaf T
    J Am Coll Cardiol; 2010 Feb; 55(5):454-9. PubMed ID: 20117459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment and comparison of endothelial function between dialysis and kidney transplant patients.
    Kocak H; Ceken K; Dinckan A; Mahsereci E; Yavuz A; Yucetin L; Akbas SH; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
    Transplant Proc; 2006 Mar; 38(2):416-8. PubMed ID: 16549135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.
    Downey RM; Liao P; Millson EC; Quyyumi AA; Sher S; Park J
    Am J Physiol Renal Physiol; 2017 May; 312(5):F917-F924. PubMed ID: 28274927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.
    Ghanavatian S; Diep LM; Bárány P; Heimbürger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
    Angiology; 2014 May; 65(5):443-9. PubMed ID: 23567479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.
    Kosch M; Levers A; Fobker M; Barenbrock M; Schaefer RM; Rahn KH; Hausberg M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1370-5. PubMed ID: 12808175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Dogra GK
    Nephrol Dial Transplant; 2011 Nov; 26(11):3543-9. PubMed ID: 21378155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease.
    Keskin GS; Helvacı Ö; Yayla Ç; Paşaoğlu Ö; Keskin Ç; Arınsoy T; Derici Ü
    Turk J Med Sci; 2019 Feb; 49(1):139-146. PubMed ID: 30763987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction and fetuin A levels before and after kidney transplantation.
    Caglar K; Yilmaz MI; Saglam M; Cakir E; Kilic S; Eyileten T; Sonmez A; Oguz Y; Oner K; Ors F; Vural A; Yenicesu M
    Transplantation; 2007 Feb; 83(4):392-7. PubMed ID: 17318070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipients.
    Memon L; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kotur-Stevuljevic J; Simic-Ogrizovic S; Giga V; Dopsaj V; Jelic-Ivanovic Z; Spasic S
    Dis Markers; 2013; 35(3):173-80. PubMed ID: 24167363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Saglam M; Caglar K; Verim S; Unal HU; Gok M; Demirkaya E; Gaipov A; Kayrak M; Cetinkaya H; Eyileten T; Turk S; Vural A
    Am J Med Sci; 2014 Feb; 347(2):118-24. PubMed ID: 23928544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease.
    Koivuviita N; Tertti R; Järvisalo M; Pietilä M; Hannukainen J; Sundell J; Nuutila P; Knuuti J; Metsärinne K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2773-9. PubMed ID: 19369689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of shift work on endothelial function in young cardiology trainees.
    Tarzia P; Milo M; Di Franco A; Di Monaco A; Cosenza A; Laurito M; Lanza GA; Crea F
    Eur J Prev Cardiol; 2012 Oct; 19(5):908-13. PubMed ID: 21900367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis.
    Khaira A; Mahajan S; Kumar A; Saraya A; Tiwari SC; Prakash S; Gupta A; Bhowmik D; Agarwal SK
    Ren Fail; 2011; 33(4):411-7. PubMed ID: 21529270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.
    Yilmaz MI; Sonmez A; Saglam M; Yaman H; Unal HU; Gok M; Cetinkaya H; Eyileten T; Oguz Y; Sari S; Yildirim AO; Vural A; Carrero JJ; Blanco-Colio LM
    Eur J Clin Invest; 2013 Dec; 43(12):1250-7. PubMed ID: 24112080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.